Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1

针对 1 型神经纤维瘤病的血管生成和间质性高血压

基本信息

  • 批准号:
    7267968
  • 负责人:
  • 金额:
    $ 11.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-01 至 2007-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a resubmission of an R21 application. Malignant peripheral nerve sheath tumors (MPNST) are the most common malignant tumor, and the leading cause of mortality in neurofibromatosis type 1 (NF1). Two critical issues in MPNST are neovascularization and high interstitial fluid pressure (IFP). The NG2 proteoglycan, Nf1 haploinsufficiency (Nf1+/-), and accelerated response of neovascular cells to neovascular stimuli are fundamental to both issues. The underlying hypothesis for this proposal is that neovascularization and interstitial fluid hypertension in MPNST can be counteracted by inhibiting both NG2 proteoglycan and Nf1 haploinsufficiency. We propose to establish both vasculogenic and angiogenic pericytes as targets to reduce interstitial fluid pressure and neovascularization in MPNST. Specific Aim 1. Characterize the accelerated contribution of Nf1+/- bone marrow-derived pericytes and endothelial cells to pathological vasculogenesis in NF1 mouse model. We will test whether bone marrow transplantation from wild type mice (Nf1+/+) to Nf1+/- mice reduces vasculogenesis and improves survival in MPNST. Specific Aim 2. Characterize the roles for NG2 in modulation of NF1-driven neovascularization, and in interstitial hypertension. We will determine the extent to which pericyte-NG2 contributes to neovascularization and interstitial hypertension in MPNST. We will test whether the combined inhibition of NG2 and Nf1 haploinsufficiency will maximally inhibit neovascularization due to synergy between NG2, and Nf1 haploinsufficiency. Specific Aim 3. Reveal the role for NG2 in accelerated response of Nf1 haploinsufficient neovascular cells to bFGF. Previous investigations identified bFGF hypersensitivity as a cause of excessive cell proliferation in Nf1 haploinsufficiency. We propose to determine whether there is a bFGF-driven synergistic mechanism linking Nf1 haploinsufficiency and NG2. Specific Aim 4. Identify the origin of high interstitial fluid pressure in MPNST in the NF1 mouse model. We will test whether inhibition of NG2 results in a decrease in interstitial fluid pressure due to decreasing compressive contractile forces within the tumor by decreasing the abnormal number of pericytes and their abnormal contraction properties.
描述(由申请人提供):这是一份R21申请的重新提交。恶性周围神经鞘瘤(MPNST)是最常见的恶性肿瘤,也是导致1型神经纤维瘤病(NF1)死亡的主要原因。MPNST的两个关键问题是新生血管和高间质液体压(IFP)。NG2蛋白多糖、NF1单倍体功能不全(NF1+/-)和新生血管细胞对新生血管刺激的加速反应是这两个问题的基础。这一建议的基本假设是,MPNST中的新生血管和间质液体高血压可以通过抑制NG2蛋白多糖和NF1单倍体不足来抵消。我们建议同时建立血管生成和血管生成周细胞作为靶点,以降低MPNST的间质液体压力和新生血管。具体目的1.研究NF1+/-骨髓源性周细胞和内皮细胞在NF1小鼠模型中对病理性血管生成的加速作用。我们将测试从野生型小鼠(Nf1+/+)到Nf1+/-小鼠的骨髓移植是否减少了血管生成并提高了MPNST的存活率。具体目的2.表征NG2在NF1驱动的新生血管形成和间质性高血压中的调节作用。我们将确定周细胞-NG2在MPNST中促进新生血管和间质性高血压的程度。我们将测试NG2和NF1单倍体不足的联合抑制是否会最大限度地抑制由于NG2和NF1单倍体不足之间的协同作用而导致的新生血管形成。具体目的3.揭示NG2在NF1单倍体缺陷新生血管细胞对碱性成纤维细胞生长因子加速反应中的作用。以往的研究证实,碱性成纤维细胞生长因子高敏感性是NF1单倍体功能不全患者细胞过度增殖的原因。我们建议确定是否存在碱性成纤维细胞生长因子驱动的协同机制将NF1单倍体不足与NG2联系起来。具体目的4.明确NF1小鼠模型MPNST高间质液体压的来源。我们将测试NG2的抑制是否会通过减少周细胞的异常数量及其异常收缩特性来降低肿瘤内的压缩收缩力,从而导致间质液体压力的降低。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

UGUR OZERDEM其他文献

UGUR OZERDEM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('UGUR OZERDEM', 18)}}的其他基金

Improving transcapillary transport by reducing interstitial fluid pressure
通过降低间质液压力改善跨毛细血管运输
  • 批准号:
    7387153
  • 财政年份:
    2008
  • 资助金额:
    $ 11.67万
  • 项目类别:
Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1
针对 1 型神经纤维瘤病的血管生成和间质性高血压
  • 批准号:
    7143733
  • 财政年份:
    2006
  • 资助金额:
    $ 11.67万
  • 项目类别:
Targeting Vasculogenesis and Interstitial Hypertension in Neurofibromatosis Type1
针对 1 型神经纤维瘤病的血管生成和间质性高血压
  • 批准号:
    7540125
  • 财政年份:
    2006
  • 资助金额:
    $ 11.67万
  • 项目类别:
PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1
1 型神经纤维瘤病血管生成中的周细胞
  • 批准号:
    6757878
  • 财政年份:
    2003
  • 资助金额:
    $ 11.67万
  • 项目类别:
PERICYTES IN ANGIOGENESIS IN NEUROFIBROMATOSIS TYPE 1
1 型神经纤维瘤病血管生成中的周细胞
  • 批准号:
    6797630
  • 财政年份:
    2003
  • 资助金额:
    $ 11.67万
  • 项目类别:

相似海外基金

Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
  • 批准号:
    520728-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 11.67万
  • 项目类别:
    University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
  • 批准号:
    10368760
  • 财政年份:
    2017
  • 资助金额:
    $ 11.67万
  • 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
  • 批准号:
    10669539
  • 财政年份:
    2017
  • 资助金额:
    $ 11.67万
  • 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
  • 批准号:
    9570142
  • 财政年份:
    2017
  • 资助金额:
    $ 11.67万
  • 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
  • 批准号:
    9915803
  • 财政年份:
    2017
  • 资助金额:
    $ 11.67万
  • 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
  • 批准号:
    10259999
  • 财政年份:
    2017
  • 资助金额:
    $ 11.67万
  • 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
  • 批准号:
    21580130
  • 财政年份:
    2009
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
  • 批准号:
    300985-2004
  • 财政年份:
    2005
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
  • 批准号:
    300985-2004
  • 财政年份:
    2004
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Postdoctoral Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了